CN1895407B - 止咳祛痰平喘的中药制剂及其制备方法 - Google Patents
止咳祛痰平喘的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN1895407B CN1895407B CN2006102006120A CN200610200612A CN1895407B CN 1895407 B CN1895407 B CN 1895407B CN 2006102006120 A CN2006102006120 A CN 2006102006120A CN 200610200612 A CN200610200612 A CN 200610200612A CN 1895407 B CN1895407 B CN 1895407B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix sophorae
- sophorae flavescentis
- cough
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 title claims abstract description 9
- 208000026435 phlegm Diseases 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims description 26
- 238000000034 method Methods 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 17
- 208000006673 asthma Diseases 0.000 claims abstract description 9
- 241000158748 Acronychia Species 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000008187 granular material Substances 0.000 claims description 18
- 230000006837 decompression Effects 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 229920002472 Starch Polymers 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 5
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000219000 Populus Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 239000002023 wood Substances 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000004576 sand Substances 0.000 description 11
- 239000006187 pill Substances 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 7
- 239000006188 syrup Substances 0.000 description 7
- 235000020357 syrup Nutrition 0.000 description 7
- 238000012856 packing Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- -1 electuary Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000095444 Populus davidiana Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
辅料 | 颗粒吸湿性 | 颗粒流动性 | 崩解时限(分钟) | 价格 |
淀粉 | 较好 | 较好 | 17 | 价格便宜,经济 |
糊精 | 一般 | 较好 | 16 | 一般 |
羧甲基纤维素钠 | 较好 | 较好 | 15 | 价格昂贵 |
羧甲基淀粉 | 较好 | 较好 | 15 | 价格昂贵 |
崩解剂 | 用量 | 崩解时限(分钟) | 外观性状 |
淀粉 | 2% | 20 | 易吸潮,药物稳定性差 |
羧甲基淀粉钠 | 2% | 9 | 硬度好,外观可压性及流动性均符合要求 |
二氧化硅 | 2% | 22 | 可压性及流动性均不好 |
低取代羟丙基纤维 | 2% | 15 | 硬度及外观稍差 |
辅料 | 颗粒硬度、溶化性 | 口感 |
淀粉 | 颗粒较硬,溶化性较差 | 口感较差 |
糊精 | 颗粒较硬,溶化性较差 | 口感较差 |
蔗糖 | 颗粒较硬,溶化性较较好 | 口感好 |
病例数 | 临床治愈 | 显效 | 有效 | 无效 | 总有效率% | |
白沙胶囊 | 200 | 160 | 12 | 14 | 4 | 98 |
白沙糖浆 | 200 | 150 | 20 | 10 | 20 | 90 |
止咳平喘丸 | 病例数 | 临床治愈 | 显效 | 有效 | 无效 | 总有效率% |
治疗组 | 200 | 168 | 18 | 4 | 10 | 95 |
对照组 | 90 | 40 | 23 | 12 | 10 | 89 |
止咳平喘丸 | 病例数 | 临床治愈 | 显效 | 有效 | 无效 | 总有效率% |
治疗组 | 200 | 160 | 14 | 12 | 14 | 93 |
对照组 | 90 | 40 | 23 | 12 | 10 | 89 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006102006120A CN1895407B (zh) | 2006-06-23 | 2006-06-23 | 止咳祛痰平喘的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006102006120A CN1895407B (zh) | 2006-06-23 | 2006-06-23 | 止咳祛痰平喘的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1895407A CN1895407A (zh) | 2007-01-17 |
CN1895407B true CN1895407B (zh) | 2010-12-15 |
Family
ID=37608146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006102006120A Active CN1895407B (zh) | 2006-06-23 | 2006-06-23 | 止咳祛痰平喘的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1895407B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102872251B (zh) * | 2012-10-24 | 2014-06-25 | 贵阳德昌祥药业有限公司 | 一种止咳、祛痰的糖浆剂及其制备方法 |
CN104491331B (zh) * | 2014-12-31 | 2016-01-20 | 广西半宙天龙制药有限公司 | 一种具有止咳作用的药物组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539473A (zh) * | 2003-10-30 | 2004-10-27 | 温明春 | 一种治疗哮喘的药物 |
CN1623564A (zh) * | 2003-12-01 | 2005-06-08 | 刘志林 | 一种治疗喘息型气管炎的药剂 |
-
2006
- 2006-06-23 CN CN2006102006120A patent/CN1895407B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539473A (zh) * | 2003-10-30 | 2004-10-27 | 温明春 | 一种治疗哮喘的药物 |
CN1623564A (zh) * | 2003-12-01 | 2005-06-08 | 刘志林 | 一种治疗喘息型气管炎的药剂 |
Non-Patent Citations (5)
Title |
---|
国家药典委员会.国家药品监督管理局国家中成药标准汇编(中成药地方标准上升国家标准部分)之内科分册.2002,123. * |
徐常本等.苦参的临床新用途.基层中药杂志9 2.1995,9(2),第44页. |
徐常本等.苦参的临床新用途.基层中药杂志9 2.1995,9(2),第44页. * |
钟玉.肺炎.健康生活 9.2003,(9),第36页. |
钟玉.肺炎.健康生活 9.2003,(9),第36页. * |
Also Published As
Publication number | Publication date |
---|---|
CN1895407A (zh) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN101011562B (zh) | 参芪温胆汤新剂型及其生产方法 | |
CN1895407B (zh) | 止咳祛痰平喘的中药制剂及其制备方法 | |
CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
CN107890528B (zh) | 一种治疗高尿酸血症的中药组合物及其制备方法 | |
CN101954022B (zh) | 一种用于治疗肺癌的中药组合物 | |
CN105853901A (zh) | 癌症病人放化疗期间服用的制剂及制法 | |
CN103055217B (zh) | 一种用于胃切除手术后胃肠功能恢复的药物组合物 | |
CN111467441A (zh) | 一种用于预防和治疗痛风的药物组合物、制剂及应用 | |
CN101028445B (zh) | 一种治疗鱼鳞病的中成药 | |
CN104784418A (zh) | 一种治疗腰椎间盘突出症的药物 | |
CN103736008B (zh) | 治疗乳腺癌并发健侧良性包块的药物组合物及其制备方法 | |
CN104306585B (zh) | 一种用于治疗前列腺炎的中药组合物及其制备方法与应用 | |
CN107929667A (zh) | 一种治疗痛风的壮医外用擦洗汤 | |
CN105412673A (zh) | 一种治疗桥本氏病的药物及其制备方法 | |
CN106110190B (zh) | 一种养血调经的中药组合物及中药制剂 | |
CN114470122A (zh) | 一种治疗梅毒的中药组合物及其制备方法 | |
CN104815131A (zh) | 一种用于治疗鸡痛风的药物组合物及其制备方法 | |
CN118021869A (zh) | 一种强肾中药提取物的制备方法、产品和应用 | |
CN114748440A (zh) | 芪胶升白胶囊组合物及其制法和用途 | |
CN103933515A (zh) | 一种用于治疗前列腺炎的中药及其制备方法 | |
CN110051802A (zh) | 一种复方山楂制剂的制备方法和用途 | |
CN1977940B (zh) | 一种治疗妇科疾病的中药组合物 | |
CN108938854A (zh) | 一种治疗乙肝的中药组合物及其制备方法 | |
CN102961532A (zh) | 一种治疗过敏性紫癜的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190403 Address after: 550029 Jinyang Science and Technology Industrial Park, Guiyang High-tech Industrial Development Zone, Guizhou Province (No. 11 Duyun Road) Patentee after: HANFANG PHARMA CO.,LTD. Address before: 550001 No. 13 Jiuhua Road, Guiyang City, Guizhou Province Patentee before: Guiyang Dechangxiang Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Zhisou and phlegm-eliminating Chinese medicinal preparation and its making method Effective date of registration: 20200519 Granted publication date: 20101215 Pledgee: Guizhou mingdekang Technology Center (L.P.) Pledgor: HANFANG PHARMA Co.,Ltd. Registration number: Y2020520000006 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220428 Granted publication date: 20101215 Pledgee: Guizhou mingdekang Technology Center (L.P.) Pledgor: HANFANG PHARMA CO.,LTD. Registration number: Y2020520000006 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 118 Chuangwei Road, Shawen Town, Guiyang National High tech Industrial Development Zone, Guiyang City, Guizhou Province, 550029 Patentee after: HANFANG PHARMA CO.,LTD. Country or region after: China Address before: 550029 Jinyang Science and Technology Industrial Park, Guiyang High-tech Industrial Development Zone, Guizhou Province (No. 11 Duyun Road) Patentee before: HANFANG PHARMA CO.,LTD. Country or region before: China |